Using Whole Transcriptome and Whole Exome Sequencing to Maximize Cancer Treatment
Growth of RNA sequencing allows physicians and researchers to analyze a patient’s full genetic profile.
Read MorePosted by Laurie Bonner | Jan 13, 2021 | Cancer, Molecular Diagnostics |
Growth of RNA sequencing allows physicians and researchers to analyze a patient’s full genetic profile.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Cancer |
Illumina has established oncology partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to expand the reach of TruSight Oncology.
Read MorePosted by Melanie Hamilton-Basich | Jan 8, 2021 | Covid 19, Research |
University of Birmingham Enterprise has filed a patent application covering the method and its use in diagnostic equipment, and is now seeking to license the patent for rapid product development.
Read MorePosted by Laurie Bonner | Jan 8, 2021 | Covid 19, Molecular Diagnostics |
SDNA-1000 Saliva Collection Device will be used for an extensive countrywide mandate that includes testing every UK citizen once a week.
Read MorePosted by Laurie Bonner | Dec 23, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The Randox SARS-CoV-2 IgG (RBD & NP) Array offers clinicians an opportunity to discriminate vaccinated individuals from those naturally infected by covid-19.
Read More